論文 2024年
【原著英文2024年】
Kosei Hasegawa, Shunji Takahashi, Kimio Ushijima, Masao Okadome, Kan Yonemori, Harushige Yokota, Ignace Vergote, Bradley J Monk, Krishnansu S Tewari, Keiichi Fujiwara, Jingjin Li, Shaheda Jamil, Anne Paccaly, Kazuhiro Takehara, Tomoka Usami, Yoichi Aoki, Nao Suzuki, Yoichi Kobayashi, Yoshio Yoshida, Hidemichi Watari, Frank Seebach, Israel Lowy, Melissa Mathias, Matthew G Fury, Ana Oaknin
Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer
Cancer Med. 13(18), e70236, 2024
Domenica Lorusso, Yang Xiang, Kosei Hasegawa, Giovanni Scambia, Manuel Leiva, Pier Ramos-Elias, Alejandro Acevedo, Jakub Cvek, Leslie Randall, Andrea Juliana Pereira de Santana Gomes, Fernando Contreras Mejía, Limor Helpman, Hüseyin Akıllı, Jung-Yun Lee, Valeriya Saevets, Flora Zagouri, Lucy Gilbert, Jalid Sehouli, Ekkasit Tharavichitkul, Kristina Lindemann, Nicoletta Colombo, Chih-Long Chang, Marketa Bednarikova, Hong Zhu, Ana Oaknin, Melissa Christiaens, Edgar Petru, Tomoka Usami, Peng Liu, Karin Yamada, Sarper Toker, Stephen M Keefe, Sandro Pignata, Linda R Duska; ENGOT-cx11/GOG-3047/KEYNOTE-A18 investigators
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet. 404, 1321-1332, 2024
Itamochi H, Takeshima N, Hamanishi J, Hasegawa K, Matsuura M, Miura K, Nagao S, Nakai H, Tanaka N, Tokunaga H, Nishio S, Watari H, Yokoyama Y, Kase Y, Sumino S, Kato A, Suri A, Yasuoka T, Takehara K. Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study. J Gynecol Oncol. 2024 Sep;35(5):e115. doi: 10.3802/jgo.2024.35.e115. Epub 2024 Jul 17. PMID: 39058367; PMCID: PMC11390257.
Ono M, Takai Y, Harada M, Horie A, Dai Y, Kikuchi E, Miyachi M, Yamamoto T, Fujii N, Kajiyama H, Manabe A, Yasuoka T, Katsuragi S, Mekaru K, Maezawa T, Horage Y, Kataoka S, Nakayama R, Nakajima TE, Kimura F, Shimizu C, Sugimoto K, Takae S, Yumura Y, Nishi H, Furui T, Morishige KI, Watanabe C, Osuga Y, Suzuki N. Out-of-pocket fertility preservation expenses: data from a Japanese nationwide multicenter survey. Int J Clin Oncol. 2024 Dec;29(12):1959-1966. doi: 10.1007/s10147-024-02614-z. Epub 2024 Sep 4. PMID: 39231915; PMCID: PMC11588863.
Takahashi Y, Fujiwara H, Yamamoto K, Yamaguchi S, Nagao S, Takano M, Miyamoto M, Hasegawa K, Miwa M, Yasuoka T, Yamashita S, Hirakawa T, Nagai T, Hamada Y, Uno M, Mori-Uchino M, Ohwada M, Mitsuhashi A, Satoh T, Fujiwara K, Suzuki M; GOTIC-VTE Trial Investigators. Incidence and risk factors for venous thromboembolism in gynecological cancer: the GOTIC-VTE trial. J Thromb Thrombolysis. 2025 Feb;58(2):299-308. doi: 10.1007/s11239-024-03055-1. Epub 2024 Nov 27. PMID: 39602066; PMCID: PMC11885320.
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijima, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, ….. Vicky Makker, Yong Man Kim. Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer.J Gynecol Oncol. 2024 Mar;35(2):e40. doi: 10.3802/jgo.2024.35.e40. Epub 2024 Jan 19.
Domenica Lorusso, Yang Xiang, Kosei Hasegawa, …… Tomoka Usami, …… Linda R Duska; ENGOT-cx11/GOG-3047/KEYNOTE-A18 investigators. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.Lancet. 2024 Mar 20:S0140-6736(24)00317-9. doi: 10.1016/S0140-6736(24)00317-9.
Yokoyama M, Miyakoshi K, Nakanishi S, Iwama N, Aoki S, Yasuhi I and Sugiyama T. Current status of screening and management of gestational diabetes in early pregnancy: a questionnaire survey in Japan. Diabetol Int 2024; 15: 627–631.
Kasuga Y, Miyakoshi K, Yokoyama M, Nakanishi S, Iwama N, Ichikawa R, Abiko A, Harashima S, Sugiyama T. Use of the Japanese gestational diabetes mellitus diagnostic strategy during the COVID-19 pandemic in Japan: A questionnaire survey. J Obstet Gynaecol Res. 2024;50 : 955-960.
Tomoya Kubota, Miho Nagata, Kazuko Takagi, Yasuki Ishihara, Kurumi Kojima, Yuka Uchikura, Reina Yamamoto, Ayumi Yonei, Erina Ozaki, Natsuki Kira, Satoe Takahashi, Kazuaki Homma, Yohei Miyashita, Minenori Eguchi-Ishimae, Norio Sakai, YOhihiro, Asano, Yasushi Sakata, Keiichi Ozono, Mariko Eguchim Masanori Takahashi
Hydrops fetalis due to loss of function of hNav1.4 channel via compound heterozygous variants
Jornal of Human genetics.2024. Aug 21
Gestational diabetes in early pregnancy is associated with postpartum glucose intolerance: a perspective from the Diabetes and Pregnancy Outcome for Mother and Baby study in Japan.
Yokoyama M, Miyakoshi K, Iwama N, Yamashita H, Yasuhi I, Kawasaki M, Arata N, Sato S, Imura Y, Waguri M, Kawaguchi H, Masaoka N, Nakajima Y, Hiramatsu Y, Sugiyama T.
J Diabetes Invest. 2024 Nov 28. doi: 10.1111/jdi.14368.
Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children’s Study.
Tagami K, Iwama N, Hamada H, Tomita H, Kudo R, Kumagai N, Wang H, Izumi S, Watanabe Z, Ishikuro M, Obara T, Tatsuta N, Metoki H, Ota C, Sugiyama T, Kuriyama S, Arima T, Yaegashi N, Saito M, JECS Group.
J Diabetes Investig. 2024 15:751-761. doi: 10.1111/jdi.14159
Current status of screening and management of gestational diabetes in early pregnancy: a questionnaire survey in Japan.
Yokoyama M, Miyakoshi K, Nakanishi S, Iwama N, Aoki S, Yasuhi I, Sugiyama T.
Diabetology International. 2024;15:627-631. doi: 10.1007/s13340-024-00700-1
Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study.
Yoshida A, Takata Y, Tabara Y, Maruyama K, Inoue S, Osawa H, Sugiyama T.
J Diabetes Invest. 2024 15:725-735. doi: 10.1111/jdi.14163.
Effects of levothyroxine treatment on fertility and pregnancy outcomes in subclinical hypothyroidism: a systematic review and meta-analysis of randomized controlled trials.
Sankoda A, Suzuki H, Imaizumi M, Yoshihara A, Kobayashi S, Katai M, Hamada K, Hidaka Y, Yoshihara A, Nakamura H, Kubota S, Kakita-Kobayashi M, Iwase A, Sugiyama T, Ota E, 15, Arata N.
Thyroid. 2024 34:519-530. doi: 10.1089/thy.2023.0546.
Use of the Japanese gestational diabetes mellitus diagnostic strategy during the COVID-19 pandemic in Japan: a questionnaire survey.
Kasuga Y, Miyakoshi K, Yokoyama M, Nakanishi S, Iwama N, Ichikawa R, Abiko A, Harashima S, Sugiyama T.
J Obstet Gynaecol Res. 2024 50:955-960. doi: 10.1111/jog.15929.
Associations of fasting plasma glucose and HbA1c level at less than 24 weeks of gestation with hypertensive disorders of pregnancy: The BOSHI Study.
Izumi S, Iwama N, Hamada H, Obara T, Ishikuro M, Satoh M, Murakami T, Saito M,
Ohkubo T, Sugiyama T, Kuriyama S, Yaegashi N, Hoshi K, Imai Y, Metoki H and The BOSHI Study Group.
Endocrine J. 71:979-993. doi: 10.1507/endocrj.EJ23-0568.
Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through single-strand DNA gap 2 accumulation behind replication forks.
Onji H, Tate S, Sakaue T, Kohei F, Kawaida M, Onishi N, Matsumoto T, Yamagami W, Sugiyama T, Higashiyama S, Pommier Y, Kobayashi Y, Murai J.
Oncogene. 2024 43:2475-2489. doi: 10.1038/s41388-024-03094-1.
Feasibility and efficacy of pemafibrate in the prevention of maternal high-fat intake induced glucose metabolic dysfunction in offspring.
Imai M, Liu S, Yano A, Mogi M, Sugiyama T
Biochem Pharmacol. 2024 227:116454. doi: 10.1016/j.bcp.2024.116454.
Is early pregnancy HbA1c useful to predict gestational diabetes mellitus diagnosed during mid pregnancy?
Nakanishi S, Aoki S, Iwama N, Ichiro Y, Sugiyama T, Miyakoshi K.
J Obstet Gynaecol Res. 2024 50:2211-2217. doi: 10.1111/jog.16108. Online ahead of print.
Stimulation of angiotensin II receptor subtype 2 reduces preeclampsia-like symptoms in a mouse model of preeclampsia.
Matsubara K, Matsubara Y, Uchikura Y, Sugiyama T.
Curr Issues Mol Biol. 2024;46:9760-9771
【原著和文2024年】
宇都宮美加、﨑山貴代、古田美幸、杉山 隆
母親の産後ケアニーズを構成する因子の検討と特徴
母性衛生. 64(4): 594-601, 2024
